USD 241.88
(-4.55%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 46.03 Million USD | -16.3% |
2022 | 55 Million USD | -34.8% |
2021 | 84.35 Million USD | 3725.71% |
2020 | 2.2 Million USD | -28.64% |
2019 | 3.09 Million USD | -87.71% |
2018 | 25.14 Million USD | 0.0% |
2017 | - USD | -100.0% |
2016 | 856 Thousand USD | -54.22% |
2015 | 1.87 Million USD | -34.75% |
2014 | 2.86 Million USD | -25.42% |
2013 | 3.84 Million USD | -61.04% |
2012 | 9.86 Million USD | 58.6% |
2011 | 6.21 Million USD | -17.09% |
2010 | 7.5 Million USD | -7.68% |
2009 | 8.12 Million USD | 29.56% |
2008 | 6.27 Million USD | -18.45% |
2007 | 7.68 Million USD | -11.49% |
2006 | 8.68 Million USD | -49.97% |
2005 | 17.36 Million USD | 2.27% |
2004 | 16.98 Million USD | 4.22% |
2003 | 16.29 Million USD | 16.21% |
2002 | 14.01 Million USD | -1.42% |
2001 | 14.22 Million USD | 4.01% |
2000 | 13.67 Million USD | 57.17% |
1999 | 8.7 Million USD | 19.18% |
1998 | 7.3 Million USD | 8.96% |
1997 | 6.7 Million USD | 19.64% |
1996 | 5.6 Million USD | -3.45% |
1995 | 5.8 Million USD | 31.82% |
1994 | 4.4 Million USD | 57.14% |
1993 | 2.8 Million USD | -30.0% |
1992 | 4 Million USD | 2.56% |
1991 | 3.9 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 47.95 Million USD | 0.98% |
2024 Q3 | 212 Million USD | 375.34% |
2024 Q1 | 47.48 Million USD | 3.15% |
2023 Q3 | 57.62 Million USD | 1.1% |
2023 Q2 | 57 Million USD | -5.0% |
2023 Q1 | 60 Million USD | 9.09% |
2023 FY | 46.03 Million USD | -16.3% |
2023 Q4 | 46.03 Million USD | -20.11% |
2022 FY | 55 Million USD | -34.8% |
2022 Q4 | 55 Million USD | -34.14% |
2022 Q3 | 83.5 Million USD | -25.98% |
2022 Q2 | 112.81 Million USD | 8.43% |
2022 Q1 | 104.04 Million USD | 23.33% |
2021 Q3 | 1.68 Million USD | -14.62% |
2021 Q4 | 84.35 Million USD | 4915.28% |
2021 FY | 84.35 Million USD | 3725.71% |
2021 Q2 | 1.97 Million USD | -12.87% |
2021 Q1 | 2.26 Million USD | 2.54% |
2020 Q3 | 2.42 Million USD | -10.27% |
2020 FY | 2.2 Million USD | -28.64% |
2020 Q4 | 2.2 Million USD | -9.18% |
2020 Q1 | 2.82 Million USD | -8.51% |
2020 Q2 | 2.7 Million USD | -4.28% |
2019 Q4 | 3.09 Million USD | -79.4% |
2019 Q3 | 15 Million USD | -13.93% |
2019 Q2 | 17.42 Million USD | -21.29% |
2019 Q1 | 22.14 Million USD | -11.93% |
2019 FY | 3.09 Million USD | -87.71% |
2018 Q3 | 33.85 Million USD | -14.44% |
2018 Q1 | 49.28 Million USD | 0.0% |
2018 Q2 | 39.57 Million USD | -19.71% |
2018 Q4 | 25.14 Million USD | -25.74% |
2018 FY | 25.14 Million USD | 0.0% |
2017 FY | - USD | -100.0% |
2017 Q1 | 600 Thousand USD | -29.91% |
2017 Q3 | 84 Thousand USD | -75.44% |
2017 Q2 | 342 Thousand USD | -43.0% |
2017 Q4 | - USD | -100.0% |
2016 Q2 | 1.36 Million USD | -15.69% |
2016 Q4 | 856 Thousand USD | -23.02% |
2016 Q3 | 1.11 Million USD | -18.53% |
2016 Q1 | 1.61 Million USD | -13.42% |
2016 FY | 856 Thousand USD | -54.22% |
2015 Q4 | 1.87 Million USD | -11.83% |
2015 Q2 | 2.37 Million USD | -9.51% |
2015 FY | 1.87 Million USD | -34.75% |
2015 Q3 | 2.12 Million USD | -10.51% |
2015 Q1 | 2.61 Million USD | -8.62% |
2014 Q1 | 3.6 Million USD | -6.32% |
2014 FY | 2.86 Million USD | -25.42% |
2014 Q4 | 2.86 Million USD | -7.9% |
2014 Q3 | 3.11 Million USD | -7.3% |
2014 Q2 | 3.35 Million USD | -6.75% |
2013 Q3 | 9.28 Million USD | -3.99% |
2013 Q2 | 9.67 Million USD | -3.82% |
2013 Q1 | 10.05 Million USD | 1.97% |
2013 Q4 | 3.84 Million USD | -58.62% |
2013 FY | 3.84 Million USD | -61.04% |
2012 Q3 | 5.78 Million USD | -2.45% |
2012 FY | 9.86 Million USD | 58.6% |
2012 Q1 | 6.07 Million USD | -2.33% |
2012 Q2 | 5.92 Million USD | -2.39% |
2012 Q4 | 9.86 Million USD | 70.54% |
2011 FY | 6.21 Million USD | -17.09% |
2011 Q1 | 7.34 Million USD | -2.09% |
2011 Q4 | 6.21 Million USD | -2.28% |
2011 Q3 | 6.36 Million USD | -2.69% |
2011 Q2 | 6.54 Million USD | -10.96% |
2010 Q1 | 7.97 Million USD | -1.91% |
2010 FY | 7.5 Million USD | -7.68% |
2010 Q3 | 7.65 Million USD | -2.0% |
2010 Q4 | 7.5 Million USD | -2.05% |
2010 Q2 | 7.81 Million USD | -1.96% |
2009 Q4 | 8.12 Million USD | -1.88% |
2009 Q2 | 8.39 Million USD | -1.79% |
2009 Q1 | 8.54 Million USD | 36.24% |
2009 FY | 8.12 Million USD | 29.56% |
2009 Q3 | 8.28 Million USD | -1.32% |
2008 Q1 | 7.34 Million USD | -4.54% |
2008 FY | 6.27 Million USD | -18.45% |
2008 Q4 | 6.27 Million USD | -5.45% |
2008 Q3 | 6.63 Million USD | -5.09% |
2008 Q2 | 6.98 Million USD | -4.8% |
2007 Q3 | 8.03 Million USD | -4.09% |
2007 Q4 | 7.68 Million USD | -4.31% |
2007 Q1 | 8.32 Million USD | -4.18% |
2007 FY | 7.68 Million USD | -11.49% |
2007 Q2 | 8.37 Million USD | 0.66% |
2006 Q1 | 15.38 Million USD | -11.42% |
2006 Q3 | 11.02 Million USD | -13.53% |
2006 Q4 | 8.68 Million USD | -21.22% |
2006 FY | 8.68 Million USD | -49.97% |
2006 Q2 | 12.75 Million USD | -17.08% |
2005 Q1 | 16.8 Million USD | -1.01% |
2005 Q4 | 17.36 Million USD | 4.47% |
2005 Q2 | 17.35 Million USD | 3.24% |
2005 FY | 17.36 Million USD | 2.27% |
2005 Q3 | 16.62 Million USD | -4.21% |
2004 Q2 | 15.62 Million USD | -0.91% |
2004 Q4 | 16.98 Million USD | 4.81% |
2004 FY | 16.98 Million USD | 4.22% |
2004 Q1 | 15.77 Million USD | -3.21% |
2004 Q3 | 16.2 Million USD | 3.68% |
2003 Q4 | 16.29 Million USD | 1.54% |
2003 FY | 16.29 Million USD | 16.21% |
2003 Q1 | 14.35 Million USD | 2.42% |
2003 Q3 | 16.04 Million USD | 5.1% |
2003 Q2 | 15.26 Million USD | 6.32% |
2002 Q3 | 13.54 Million USD | -11.03% |
2002 Q4 | 14.01 Million USD | 3.48% |
2002 Q2 | 15.22 Million USD | -5.49% |
2002 Q1 | 16.11 Million USD | 13.3% |
2002 FY | 14.01 Million USD | -1.42% |
2001 FY | 14.22 Million USD | 4.01% |
2001 Q1 | 16.44 Million USD | 20.25% |
2001 Q2 | 15.41 Million USD | -6.24% |
2001 Q3 | 16.01 Million USD | 3.85% |
2001 Q4 | 14.22 Million USD | -11.17% |
2000 FY | 13.67 Million USD | 57.17% |
2000 Q1 | 17.3 Million USD | 98.91% |
2000 Q2 | 16.72 Million USD | -3.38% |
2000 Q3 | 15.78 Million USD | -5.62% |
2000 Q4 | 13.67 Million USD | -13.36% |
1999 Q2 | 8.8 Million USD | -3.3% |
1999 Q4 | 8.7 Million USD | 1.16% |
1999 Q3 | 8.6 Million USD | -2.27% |
1999 FY | 8.7 Million USD | 19.18% |
1999 Q1 | 9.1 Million USD | 24.66% |
1998 Q1 | 7 Million USD | 4.48% |
1998 Q4 | 7.3 Million USD | 43.14% |
1998 FY | 7.3 Million USD | 8.96% |
1998 Q3 | 5.1 Million USD | -17.74% |
1998 Q2 | 6.2 Million USD | -11.43% |
1997 Q2 | 7.4 Million USD | -6.33% |
1997 Q1 | 7.9 Million USD | 41.07% |
1997 Q3 | 7.1 Million USD | -4.05% |
1997 Q4 | 6.7 Million USD | -5.63% |
1997 FY | 6.7 Million USD | 19.64% |
1996 Q3 | 5.7 Million USD | -8.06% |
1996 FY | 5.6 Million USD | -3.45% |
1996 Q4 | 5.6 Million USD | -1.75% |
1996 Q2 | 6.2 Million USD | 0.0% |
1996 Q1 | 6.2 Million USD | 6.9% |
1995 FY | 5.8 Million USD | 31.82% |
1995 Q1 | 4.2 Million USD | -4.55% |
1995 Q3 | 5.1 Million USD | 8.51% |
1995 Q2 | 4.7 Million USD | 11.9% |
1995 Q4 | 5.8 Million USD | 13.73% |
1994 Q1 | 2.9 Million USD | 3.57% |
1994 FY | 4.4 Million USD | 57.14% |
1994 Q3 | 4.1 Million USD | -4.65% |
1994 Q4 | 4.4 Million USD | 7.32% |
1994 Q2 | 4.3 Million USD | 48.28% |
1993 Q4 | 2.8 Million USD | 0.0% |
1993 FY | 2.8 Million USD | -30.0% |
1992 Q4 | 4 Million USD | 0.0% |
1992 FY | 4 Million USD | 2.56% |
1991 Q4 | 3.9 Million USD | 0.0% |
1991 FY | 3.9 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Alphatec Holdings, Inc. | 541.67 Million USD | 91.501% |
Nemaura Medical Inc. | 20.03 Million USD | -129.839% |
NeuroPace, Inc. | 72.39 Million USD | 36.409% |
LENSAR, Inc. | 2.3 Million USD | -1893.807% |
Rapid Micro Biosystems, Inc. | 7.34 Million USD | -526.695% |
TriSalus Life Sciences, Inc. | 1.59 Million USD | -2786.332% |
Apyx Medical Corporation | 38.5 Million USD | -19.574% |
Cutera, Inc. | 431.91 Million USD | 89.341% |
STRATA Skin Sciences, Inc. | 15.63 Million USD | -194.486% |
BioSig Technologies, Inc. | 452 Thousand USD | -10085.177% |
Accelerate Diagnostics, Inc. | 39.22 Million USD | -17.381% |
Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 97.262% |
Axonics, Inc. | 27.61 Million USD | -66.698% |
IRIDEX Corporation | 2.74 Million USD | -1576.511% |
PROCEPT BioRobotics Corporation | 79.2 Million USD | 41.875% |
TELA Bio, Inc. | 42.78 Million USD | -7.613% |
Tivic Health Systems, Inc. | 369 Thousand USD | -12376.152% |
RxSight, Inc. | 3.01 Million USD | -1428.453% |
Align Technology, Inc. | 96.96 Million USD | 52.524% |
INVO Bioscience, Inc. | 8.68 Million USD | -430.163% |
electroCore, Inc. | 626 Thousand USD | -7254.153% |
Telesis Bio, Inc. | 34.38 Million USD | -33.906% |
Viemed Healthcare, Inc. | 10.27 Million USD | -348.215% |
Quipt Home Medical Corp. | 98.94 Million USD | 53.471% |
Anika Therapeutics, Inc. | 29.03 Million USD | -58.546% |
Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -1860.69% |
Lucid Diagnostics Inc. | 15.25 Million USD | -201.783% |
Dynatronics Corporation | 6.68 Million USD | -588.357% |
Modular Medical, Inc. | 1.19 Million USD | -3768.655% |
ReShape Lifesciences Inc. | 262 Thousand USD | -17471.374% |
Talis Biomedical Corporation | 19.66 Million USD | -134.071% |
PetVivo Holdings, Inc. | 1.36 Million USD | -3272.575% |
InMode Ltd. | 9.01 Million USD | -410.558% |
Envoy Medical, Inc. | 404 Thousand USD | -11295.297% |
Bruker Corporation | 1.37 Billion USD | 96.663% |
Helius Medical Technologies, Inc. | 57 Thousand USD | -80666.667% |
DexCom, Inc. | 2.59 Billion USD | 98.225% |
Nexalin Technology, Inc. | 4463.00 USD | -1031425.879% |
PAVmed Inc | 48.72 Million USD | 5.517% |
Viveve Medical, Inc. | 5.34 Million USD | -760.666% |
Cerus Corporation | 95.99 Million USD | 52.044% |
Movano Inc. | 252 Thousand USD | -18168.651% |
Cytek Biosciences, Inc. | 33.17 Million USD | -38.774% |
Nexalin Technology, Inc. | 4463.00 USD | -1031425.879% |
IceCure Medical Ltd | 599 Thousand USD | -7585.643% |
Tandem Diabetes Care, Inc. | 415.66 Million USD | 88.925% |
enVVeno Medical Corporation | 1.4 Million USD | -3183.666% |
908 Devices Inc. | 5.94 Million USD | -674.382% |
ClearPoint Neuro, Inc. | 13.94 Million USD | -230.227% |
Orthofix Medical Inc. | 134.19 Million USD | 65.695% |
Surmodics, Inc. | 29.4 Million USD | -56.562% |
Nuwellis, Inc. | 981 Thousand USD | -4592.864% |
Outset Medical, Inc. | 136.18 Million USD | 66.196% |
Venus Concept Inc. | 79.69 Million USD | 42.235% |
iRhythm Technologies, Inc. | 129.82 Million USD | 64.539% |
Treace Medical Concepts, Inc. | 70.3 Million USD | 34.516% |
Nano-X Imaging Ltd. | 8.39 Million USD | -448.321% |
Aethlon Medical, Inc. | 940.31 Thousand USD | -4795.907% |
Inogen, Inc. | 21.92 Million USD | -109.994% |
IRadimed Corporation | 2.04 Million USD | -2153.354% |
MaxCyte, Inc. | 18.74 Million USD | -145.622% |
Pulmonx Corporation | 41.42 Million USD | -11.136% |
PAVmed Inc. | 48.72 Million USD | 5.517% |
iCAD, Inc. | 461 Thousand USD | -9886.334% |
OrthoPediatrics Corp. | 23.76 Million USD | -93.758% |
DIH Holding US, Inc. Warrants | 1.99 Million USD | -2205.885% |
Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -9257.285% |
NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -24865.835% |
SI-BONE, Inc. | 38.99 Million USD | -18.068% |
Semler Scientific, Inc. | 70 Thousand USD | -65667.143% |
Beyond Air, Inc. | 17.83 Million USD | -158.098% |
FONAR Corporation | 41.67 Million USD | -10.464% |
AxoGen, Inc. | 69.29 Million USD | 33.561% |
Biotricity, Inc. | 23.87 Million USD | -92.795% |
Cytosorbents Corporation | 18.31 Million USD | -151.388% |
ZimVie Inc. | 521.92 Million USD | 91.179% |
Tactile Systems Technology, Inc. | 50.37 Million USD | 8.611% |
Inari Medical, Inc. | 32.04 Million USD | -43.655% |
DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -2205.885% |
QT Imaging Holdings, Inc. | 3.07 Million USD | -1399.058% |
Sight Sciences, Inc. | 35.41 Million USD | -29.997% |
Insulet Corporation | 1.44 Billion USD | 96.822% |
Profound Medical Corp. | 7.9 Million USD | -482.719% |
Bioventus Inc. | 409.47 Million USD | 88.757% |
InspireMD, Inc. | 1.59 Million USD | -2786.332% |
BrainsWay Ltd. | 471 Thousand USD | -9674.31% |
BIOLASE, Inc. | 17.91 Million USD | -157.046% |
Heart Test Laboratories, Inc. | 1.03 Million USD | -4342.277% |
Tenon Medical, Inc. | 1.17 Million USD | -3824.723% |
Autonomix Medical, Inc. Common Stock | 1 Million USD | -4494.511% |
CVRx, Inc. | 30.61 Million USD | -50.384% |
AdaptHealth Corp. | 2.29 Billion USD | 97.994% |
Sintx Technologies, Inc. | 4.24 Million USD | -984.499% |
Acutus Medical, Inc. | 38.47 Million USD | -19.642% |
Vivos Therapeutics, Inc. | 1.99 Million USD | -2207.619% |
NanoVibronix, Inc. | 5000.00 USD | -920640.0% |
Quanterix Corporation | 41.46 Million USD | -11.029% |
LivaNova PLC | 640.4 Million USD | 92.811% |
Co-Diagnostics, Inc. | 2.99 Million USD | -1439.407% |
Varex Imaging Corporation | 469.5 Million USD | 90.194% |
Vivani Medical, Inc. | 20.69 Million USD | -122.444% |
Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -1860.69% |
Sensus Healthcare, Inc. | 783 Thousand USD | -5779.566% |
Pacific Biosciences of California, Inc. | 933.93 Million USD | 95.071% |
TransMedics Group, Inc. | 515.94 Million USD | 91.077% |
ReWalk Robotics Ltd. | 1.9 Million USD | -2319.18% |
NeuroMetrix, Inc. | 240.87 Thousand USD | -19012.323% |
Spectral AI, Inc. | 1.28 Million USD | -3471.528% |
Hyperfine, Inc. | 185 Thousand USD | -24784.865% |
Establishment Labs Holdings Inc. | 192.22 Million USD | 76.05% |
Biomerica, Inc. | 785 Thousand USD | -5764.586% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 449.48 Thousand USD | -10142.212% |
Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -12338.902% |
Silk Road Medical, Inc | 84.63 Million USD | 45.604% |